An endoscopic observation of intraductal papillary lesion Kohji EnomotoTakashi TsumanumaMasaki Kitajima Original Article Pages: 200 - 203
Function of estrogen receptors in breast cancer Malcolm G. ParkerShaun M. CowleyRoger White OriginalPaper Pages: 204 - 208
Multidrug resistance and prodrug activation for cancer gene therapy of breast cancer Taruma FujiiS. Q. FuAlbert Deisseroth OriginalPaper Pages: 210 - 212
Therapy of primary breast cancer in the 21st century: A prediction Hans-Jörg SennVéronique Dupont LampertBeat Thürlimann OriginalPaper Pages: 213 - 220
Anthracycline-resistant breast cancer Gabriel N. HortobagyiXavier PivotLina Asmar OriginalPaper Pages: 221 - 227
Computer aided diagnosis of breast cancer on mammograms Kunio DoiMaryellen L. GigerRobert A. Schmidt OriginalPaper Pages: 228 - 233
The clinical value of microsatellite instability and a loss in heterozygosity in sporadic breast cancers Hirotaka IwaseHiroji IwataShunzo Kobayashi OriginalPaper Pages: 234 - 238
Clinicopathological features of hereditary breast cancer Tadashi NomizuAtsuo TsuchiyaYoshio Miki OriginalPaper Pages: 239 - 242
Correlation of allelic losses and clinicopathological factors in primary breast cancers Mitsuru EmiSatoshi MatsumotoYusuke Nakamura OriginalPaper Pages: 243 - 246
Detection of numerical alterations of chromosomes 3, 7, 17 and X in low-grade intracystic papillary tumors of the breast by multi-color fluorescencein situ hybridization Hitosmi TsudaTeruko TakarabeSetsuo Hirohashi OriginalPaper Pages: 247 - 252
Molecular targeting for epidermal growth factor receptor expressed on breast cancer cells by human fusion protein Masakazu UedaKyriakos PsarrasMasaharu Seno OriginalPaper Pages: 253 - 255
BRCA1 andBRCA2 germline mutations in Japanese with hereditary breast cancer families Takashi FukutomiToshikazu UshijimaHitoshi Tsuda OriginalPaper Pages: 256 - 258
Immunohistochemical detection of P-glycoprotein in breast cancer and its significance as a prognostic factor Fumine TsukamotoEiichi ShibaShin-Ichiro Ai OriginalPaper Pages: 259 - 263
A humanized Anti-c-erbB-2 monoclonal antibody for the treatment of breast cancer Yutaka TokudaAkira OkumuraTomoo Tajima OriginalPaper Pages: 269 - 272
The clinical utility of docetaxel in adriamycin resistant breast cancer Isamu AdachiTetsuo Taguchi OriginalPaper Pages: 273 - 279
Clinical use of contrast-enhanced computed tomography for decision making in breast conserving surgery Sadako Akashi-TanakaTakashi FukutomiHitoshi Tsuda OriginalPaper Pages: 280 - 284
The role of contrast-enhanced high resolution MRI in the surgical planning of breast cancer Hideko HiramatsuKohji EnomotoRyoichi Hiramatsu OriginalPaper Pages: 285 - 290
Dynamic MR imaging and tumor angiogenesis in DMBA-induced rat breast cancer: Three dimensional (3D) reconstructed image analysis of tumor microvessels by confocal laser scanning microscopy Kazuhiko YasumuraKenji OgawaR. Yoshiyuki Osamura OriginalPaper Pages: 291 - 296
99mTc-MIBI SPECT compared with201TI SPECT for the detection of breast cancer and lymph node metastasis Hirotaka KuboNobuyoshi FukumitsuYoji Yamazaki OriginalPaper Pages: 297 - 302
Histological study of local reactions of bone metastatic foci of breast cancer Makio Mukai OriginalPaper Pages: 303 - 305
Diagnostic imaging of bone metastasis from breast cancer Atsushi RuboSuketaka MomoshimaHay Shiga OriginalPaper Pages: 306 - 310
A new endocrine therapy strategy for bone metastasis of breast cancer: The effect of biological response modifiers and 22-oxacarcitriol on animal models Yuichi IinoTakao YokoeYasuo Morishita OriginalPaper Pages: 311 - 313
